Updated:
Janssen Vaccines & Prevention B.V.
Janssen Vaccines & Prevention B.V. is the Johnson & Johnson vaccine subsidiary headquartered in Leiden, Netherlands.
Janssen Vaccines & Prevention B.V.
Janssen Vaccines & Prevention B.V. was established as a subsidiary of Johnson & Johnson to specialize in vaccine research and production. Based in Leiden, the Netherlands, the firm leverages a legacy of pharmaceutical innovation to address global health challenges. Its wealth origin traces to Johnson & Johnson's public company structure, not a private family. The firm's strategy centers on infectious disease vaccines, including a widely-distributed COVID-19 adenovirus-based vaccine. It operates across R&D, clinical trials, and manufacturing, with a focus on respiratory diseases and emerging pathogens. The geographic footprint spans Europe and the US, with manufacturing in Leiden and partnership networks in Africa. Team size and AUM are not publicly disclosed. The firm operates as part of Johnson & Johnson's research and development network. No recent operational events are available from public records. A structural differentiator is its position within a diversified healthcare conglomerate, Johnson & Johnson. This provides capital stability and regulatory infrastructure while the firm focuses on vaccine-specific science.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
Netherlands
City
Leiden
Corporate office
Leiden, Netherlands
Sector focus
Frequently asked questions
Who runs investment decisions at Janssen Vaccines & Prevention B.V.?
The firm operates as a subsidiary of Johnson & Johnson, with leadership appointed by the parent company. Specific investment decision-makers are not publicly named.
Is Janssen Vaccines & Prevention B.V. structured as a family office or a corporate entity?
It is a corporate subsidiary of Johnson & Johnson, not a family office. The firm is a limited-liability company registered in the Netherlands.
What investment stages does Janssen Vaccines & Prevention B.V. typically target?
The firm focuses on vaccine development from preclinical through clinical trials to regulatory approval. It does not engage in external fund commitments or direct private equity deals.
Which sectors does Janssen Vaccines & Prevention B.V. explicitly avoid?
By mandate, the firm operates exclusively in vaccine research and manufacturing. It avoids financial services, real estate, and all non-pharmaceutical sectors.
How is Janssen Vaccines & Prevention B.V. related to Johnson & Johnson?
The firm is a wholly-owned Dutch subsidiary of Johnson & Johnson, focusing on vaccines. It was formed as part of the wide-ranging Janssen Pharmaceuticals division.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: